Resonant Capital Advisors’s iShares iBonds Dec 2031 Term Corporate ETF IBDW Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$1.47M Sell
70,766
-5,839
-8% -$122K 0.07% 156
2026
Q1
$1.6M Buy
76,605
+35,582
+87% +$751K 0.08% 143
2025
Q4
$868K Buy
41,023
+8,319
+25% +$176K 0.05% 177
2025
Q3
$694K Buy
+32,704
New +$689K 0.04% 202

Other funds holding IBDW

Resonant Capital Advisors's IBDW Position: Q2 2026 in Review

Resonant Capital Advisors reduced its iShares iBonds Dec 2031 Term Corporate ETF (IBDW) stake by 7.6% in Q2 2026, selling an estimated $122K and leaving 70,766 shares worth $1.47M. The position accounts for 0.07% of the portfolio, ranked #156.

Resonant Capital Advisors first reported a position in IBDW in Q3 2025 and has held it in 4 quarters since. The position peaked at $1.6M in Q1 2026. 290 funds tracked by Wall St. Rank hold IBDW as of Q2 2026.

  • Resonant Capital Advisors held 70,766 shares of iShares iBonds Dec 2031 Term Corporate ETF worth $1.47M as of Q2 2026.
  • Resonant Capital Advisors sold 5,839 iShares iBonds Dec 2031 Term Corporate ETF shares in Q2 2026, an estimated $122K.
  • iShares iBonds Dec 2031 Term Corporate ETF made up 0.07% of Resonant Capital Advisors's portfolio in Q2 2026, its #156 holding.
  • Resonant Capital Advisors first reported a position in iShares iBonds Dec 2031 Term Corporate ETF in Q3 2025 and has held it in 4 quarters since.
  • Resonant Capital Advisors's iShares iBonds Dec 2031 Term Corporate ETF position peaked at $1.6M in Q1 2026.
  • 290 funds tracked by Wall St. Rank held iShares iBonds Dec 2031 Term Corporate ETF as of Q2 2026.

Based on Resonant Capital Advisors's 13F filing for Q2 2026, filed 27 Jul 2026.